Argo CK - Search Results

1

Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis.

Stine JG, Shah NL, Argo CK, Pelletier SJ, Caldwell SH, Northup PG. Stine JG, et al. Among authors: argo ck. Liver Transpl. 2015 Aug;21(8):1016-21. doi: 10.1002/lt.24134. Epub 2015 Jul 1. Liver Transpl. 2015. PMID: 25845711 Free PMC article.

2

Therapy of NAFLD: antioxidants and cytoprotective agents.

Chang CY, Argo CK, Al-Osaimi AM, Caldwell SH. Chang CY, et al. Among authors: argo ck. J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S51-60. doi: 10.1097/01.mcg.0000168648.79034.67. J Clin Gastroenterol. 2006. PMID: 16540769 Review.

3

Therapy of NAFLD: insulin sensitizing agents.

Caldwell SH, Argo CK, Al-Osaimi AM. Caldwell SH, et al. Among authors: argo ck. J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S61-6. doi: 10.1097/01.mcg.0000168647.71411.48. J Clin Gastroenterol. 2006. PMID: 16540770 Review.

4

Enlarged hepatocytes in NAFLD examined with osmium fixation: does microsteatosis underlie cellular ballooning in NASH?

Caldwell SH, Redick JA, Chang CY, Davis CA, Argo CK, Al Osaimi KA. Caldwell SH, et al. Among authors: argo ck. Am J Gastroenterol. 2006 Jul;101(7):1677-8. doi: 10.1111/j.1572-0241.2006.00627_8.x. Am J Gastroenterol. 2006. PMID: 16863583 No abstract available.

5

Donor factors predicting recipient survival after liver retransplantation: the retransplant donor risk index.

Northup PG, Pruett TL, Kashmer DM, Argo CK, Berg CL, Schmitt TM. Northup PG, et al. Among authors: argo ck. Am J Transplant. 2007 Aug;7(8):1984-8. doi: 10.1111/j.1600-6143.2007.01887.x. Am J Transplant. 2007. PMID: 17617863 Free article.

6

Divergent effects of peroxisome proliferator-activated receptor-gamma ligands in human and mouse nonalcoholic steatohepatitis.

Caldwell SH, Argo CK. Caldwell SH, et al. Among authors: argo ck. Hepatology. 2007 Aug;46(2):285-7. doi: 10.1002/hep.21881. Hepatology. 2007. PMID: 17661403 No abstract available.

7

Statins in liver disease: a molehill, an iceberg, or neither?

Argo CK, Loria P, Caldwell SH, Lonardo A. Argo CK, et al. Hepatology. 2008 Aug;48(2):662-9. doi: 10.1002/hep.22402. Hepatology. 2008. PMID: 18666246 Review.

8

Advanced recipient age (>60 years) alone should not be a contraindication to liver retransplantation.

Schmitt TM, Kumer SC, Pruett TL, Argo CK, Northup PG. Schmitt TM, et al. Among authors: argo ck. Transpl Int. 2009 Jun;22(6):601-5. doi: 10.1111/j.1432-2277.2009.00845.x. Epub 2009 Feb 10. Transpl Int. 2009. PMID: 19220825 Free article.

9

Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis.

Caldwell SH, de Freitas LA, Park SH, Moreno ML, Redick JA, Davis CA, Sisson BJ, Patrie JT, Cotrim H, Argo CK, Al-Osaimi A. Caldwell SH, et al. Among authors: argo ck. Hepatology. 2009 Jun;49(6):1888-95. doi: 10.1002/hep.22851. Hepatology. 2009. PMID: 19274750

10

Thiazolidinediones for the treatment in NASH: sustained benefit after drug discontinuation?

Argo CK, Iezzoni JC, Al-Osaimi AM, Caldwell SH. Argo CK, et al. J Clin Gastroenterol. 2009 Jul;43(6):565-8. doi: 10.1097/MCG.0b013e31818f4fc2. J Clin Gastroenterol. 2009. PMID: 19318980

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page